HDT Bio Corp. is a biopharmaceutical company developing drugs for immunotherapy of cancers and infectious diseases. Our products are designed to be cost-effective solutions to unmet medical needs and complementary to existing, cutting-edge immunotherapies.
Location: United States, Washington, Seattle
Member count: 11-50
Total raised: $9.3M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | Zoic Capit... | zoiccapita... |
Funding Rounds 4
| Date | Series | Amount | Investors | Deal News |
| 11.08.2022 | Grant | $1.8M | - | geekwire.c... |
| 20.07.2022 | Grant | $1.5M | - | - |
| 16.02.2021 | - | $3M | Zoic Capit... | - |
| 06.10.2020 | Seed | $3M | - | finsmes.co... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 11.08.2022 | Seattle st... | HDT Bio CEO Steve Reed. (HDT B... | - | Charlotte ... | geekwire.c... |
| 16.08.2021 | Covid-19 r... | Four months after Rigel anno... | - | Josh Sulli... | endpts.com... |
| 17.05.2021 | HDT Bio Aw... | HDT Bio Corp., a developer of ... | - | - | marketscre... |
| 05.10.2020 | HDT Bio Co... | HDT Bio Corp., a Seattle, WA-b... | USA | - | finsmes.co... |
| 05.10.2020 | Seattle st... | Steve Reed, CEO of HDT Bio. (H... | - | Lisa Stiff... | geekwire.c... |
| 05.10.2020 | Seattle st... | [Update 2/16/21: HDT Bio annou... | - | Lisa Stiff... | geekwire.c... |